cell proliferation assay versus cell viability assays

15
Cell proliferation assay versus cell viability assays Lecture 4

Upload: shafira-sears

Post on 31-Dec-2015

48 views

Category:

Documents


0 download

DESCRIPTION

Cell proliferation assay versus cell viability assays. Lecture 4. Assays Based on Cell Proliferation. Cell counts can be used to determine the effect of various compounds on cell proliferation, but at least in the early stages of testing, a complete growth curve is required. Growth Cycle: - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Cell proliferation assay versus cell viability assays

Cell proliferation assay versus cell viability assays

Lecture 4

Page 2: Cell proliferation assay versus cell viability assays

Assays Based on Cell Proliferation

• Cell counts can be used to determine the effect of various compounds on cell proliferation, but at least in the early stages of testing, a complete growth curve is required.

• Growth Cycle: - After subculture, cells progress through a characteristic growth

pattern of lag phase, exponential, or log phase, and stationary, or plateau phase.

- population doubling time (PDT) during exponential growth- The maximum cell density achieved in the plateau phase

Page 3: Cell proliferation assay versus cell viability assays

Why do we need PDT?

• To quantify the response of the cells to different inhibitory orstimulatory culture conditions.

• To monitor of the culture during serial passage and enablesthe calculation of cell yields and the dilution factor requiredat subculture.

Page 4: Cell proliferation assay versus cell viability assays
Page 5: Cell proliferation assay versus cell viability assays

• The PDT derived from a growth curve should not beconfused with the cell cycle or generation time

- what are the differences? • The cell cycle time is measured from one point in the cell cycle

until the same point is reached again.

• PDT is an average figure

Page 6: Cell proliferation assay versus cell viability assays

• PDTs vary :- 12 to 15 h in rapidly growing mouse leukemias,- 24 to 36 h in many adherent continuous cell lines- 60 or 72 h in finite cell lines.- Some cell lines have even slower rate.

Page 7: Cell proliferation assay versus cell viability assays

Analysis of Monolayer Growth Curves

• (1) Calculate the number of cells per well and cells /ml

• (2) Plot the cell density (cells/cm2) and the cell concentration(cells/mL), both on a log scale, against time on a linearscale

• (3) Determine the lag time, PDT, and plateau density

• (4) Establish the appropriate starting density for routine passage . Repeat the growth curve at different cell concentrations if necessary

• Compare growth curves under different conditions, and try to interpret the data

Page 8: Cell proliferation assay versus cell viability assays
Page 9: Cell proliferation assay versus cell viability assays

MTT

• In cases where there are many samples, a single point in time—such as the number of cells three to five days after exposure—can be used. The time should be selected as within the log phase, and preferably mid-log phase, of control cells.

• The most popular are 96-well microtitration plates or icroplates ,each well having 28 to 32 mm2 of growth area, 0.1 or 0.2 mL medium, and up to 1 × 105 cells.

Page 10: Cell proliferation assay versus cell viability assays
Page 11: Cell proliferation assay versus cell viability assays

• MTT is a yellow water-soluble tetrazolium dye that is reduced by live, but not dead, cells to a purple formazan product that is insoluble in aqueous solutions.

• This cellular reduction involves the pyridine nucleotide cofactors NADH and NADPH (36). The formazan crystals formed are solubilized and the resulting colored solution is quantified using a scanning multiwell spectrophotometer (ELISA reader).

Page 12: Cell proliferation assay versus cell viability assays
Page 13: Cell proliferation assay versus cell viability assays
Page 14: Cell proliferation assay versus cell viability assays

MTT Assay

MCF12A,MCF7,MDA-MB-231, FG0 and DNB cells

Plate cells in 96 microplates

48 hours settle

Perform a dose curve of AJ-5 For 48 hours

Add MTT solutions and read over night

AJ-5 Anti-proliferative effect

MCF7 = 0.17 MDA-MB-231 = 0.19

DNB = 0.4631

FG0= 0.4049

CT-1= 0.4296

IC50 (µM)

0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

-20

0

20

40

60

80

100

120

MCF7

MDA-MB-231

FG0

DNB

CT-1

AJ-5 concentration (µM)

Cell

surv

ival

(% o

f con

trol

)

AJ-5 exerts potent anti-proliferative activities against human breast cancer cells

Page 15: Cell proliferation assay versus cell viability assays